Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Shapiro Capital Cuts John Bean Technologies Stake to 3.2%

Shapiro Capital Management, John Bean Technologies Corp: Shapiro Capital Management recently reported cutting down its position in John Bean Technologies Corp (NYSE:JBT) to 931,336 shares, versus some 2.54 million shares disclosed in its latest 13F filing. The new position represents  3.22% of John Bean and has a value of over $23.29 million at the current stock price of the company.

John Bean Technologies Corporation

John Bean is engaged in technology services for food processing and air transportation, and it has won several contracts recently. At the beginning of September, Ford Motor Company awarded JBT a $10 million contract for expanding its automated vehicle guided systems. The company has already 250 such systems developed for automated material delivery installed in Ford’s plants, JBT said in a statement. The company also received a $4 million contract from Guam’s A.B. Won Pat International Airport Authority.

Chuck Royce‘s Royce & Associates is also a shareholder of John Bean Technologies, owning 381,656 shares disclosed in its latest 13F. D. E. Shaw‘s D E Shaw & Co and Jim Simons‘ Renaissance Technologies are long as well.

Disclosure: none

Recommended Reading:

Is This the End of Steven Cohen’s Insider Trading Battle?

EJF Capital Gets Into American Homes 4 Rent

Kyle Bass Reveals Why He Bought J.C. Penney Stock

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!